20.12.2013 Views

Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Somatic genetics<br />

Ultrastructure, antigenic composition, and<br />

DNA- content of inverted papilloma cells<br />

have been non-contributory to the diagnosis<br />

in the few evaluated cases<br />

{68,447,1190,1406}.<br />

Prognosis<br />

If the diagnosis of inverted papilloma is<br />

strictly confined to the criteria described<br />

above, these tumours are benign.<br />

Recurrent lesions have been observed in<br />

less than 1% of the reported cases {376}<br />

and progression from pure inverted papilloma<br />

to carcinoma is extremely rare. An<br />

initial diagnosis of inverted papilloma<br />

should be challenged if progression is<br />

observed as many recurring or progressing<br />

cases have exophytic papillary structures<br />

in their initial biopsy {78}.<br />

Papillary urothelial neoplasm of low<br />

malignant potential<br />

S.L. Johansson<br />

C. Busch<br />

Definition<br />

Papillary Urothelial Neoplasm of Low<br />

Malignant Potential (PUNLMP) is a papillary<br />

urothelial tumour which resembles<br />

the exophytic urothelial papilloma, but<br />

shows increased cellular proliferation<br />

exceeding the thickness of normal<br />

urothelium.<br />

ICD-O code 8130/1<br />

Epidemiology<br />

The incidence is three cases per 100,000<br />

individuals per year. The male to female<br />

ratio is 5:1 and the mean age at diagnosis<br />

(+/- standard deviation) is 64.6 years<br />

+/-13.9 years (range 29-94) {1107}. The<br />

latter is virtually identical to that of 112<br />

patients treated at the Mayo Clinic {432}.<br />

Localization<br />

The lateral and posterior walls close to<br />

Fig. 2.35 Macroscopic appearance of a non-invasive<br />

low grade urothelial carcinoma with delicate<br />

papillae obtained at time of transurethral resection.<br />

the ureteric orifices are the preferred<br />

sites for these tumours.<br />

Clinical features<br />

Most patients present with gross or<br />

microscopic hematuria. Urine cytology<br />

is negative in most cases. Cystoscopy<br />

reveals, in general, a 1-2 cm regular<br />

tumour with a appearance reminiscent<br />

of "seaweed in the ocean". Complete<br />

transurethral resection is the treatment<br />

of choice.<br />

Histopathology<br />

The papillae of PUNLMP are discrete,<br />

slender and non fused and are lined by<br />

multilayered urothelium with minimal to<br />

absent cytologic atypia. The cell density<br />

appears to be increased compare to normal.<br />

The polarity is preserved and there<br />

is an impression of predominant order<br />

with absent to minimal variation in architectural<br />

and nuclear features. The nuclei<br />

are slightly enlarged compare to normal.<br />

The basal layers show palisading and<br />

the umbrella celI layer is often preserved.<br />

Mitoses are rare and have a basal location.<br />

These architectural and cytological<br />

features should be evaluated in well oriented,<br />

non tangentional cut areas of the<br />

neoplasm. The tumours are predominantly<br />

diploid.<br />

Prognosis<br />

The prognosis for patients with PUNLMP<br />

is excellent. Recurrences occur, but at a<br />

significantly lower frequency than in noninvasive<br />

papillary carcinomas {1610}.<br />

Rarely, these patients may present with<br />

another tumour of higher grade and/or<br />

stage, usually years after the initial diagnosis.<br />

In a series of 95 cases, 35% had<br />

recurrence but no tumour progressed. If<br />

the patients were tumour free at the first<br />

follow-up cystoscopy, 68% remained<br />

tumour free during a follow-up period of<br />

at least 5 years {1104,1110}. In another<br />

study, 47% of the patients developed<br />

local recurrence but none of the 19<br />

PUNLMP patients progressed {2071}. In<br />

contrast, in a retrospective study of 112<br />

patients with long term follow up, four<br />

patients progressed in stage, two to<br />

Fig. 2.36 Non-invasive urothelial neoplasm. Papillary<br />

urothelial neoplasm of low malignant potential.<br />

Inverted papilloma / Papillary urothelial neoplasm of low malginant potential 115

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!